SCHEMBL5791591

SCHEMBL5791591

O=[C]c1cccnc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.57
ALDH1A1 P00352 6/20 0.57
MAPT P10636 3/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
ALOX15 P16050 2/20 0.57
CYP3A4 P08684 1/20 0.57
TSHR P16473 1/20 0.57
BLM P54132 1/20 0.57
AGER Q15109 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
CYP1A2 P05177 1/20 0.50
MYC P01106 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
NAPRT Q6XQN6 3/20 0.41
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
P4HTM Q9NXG6 1/20 0.41
ASPH Q12797 1/20 0.40
KDM8 Q8N371 1/20 0.40
GAA P10253 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL15167306 0.82 KDM4E (0.55) KDM4EALDH1A1MAPTL3MBTL1ALOX15
SCHEMBL21230286 0.82 KDM4E (0.55) KDM4EALDH1A1MAPTL3MBTL1ALOX15
SCHEMBL5610319 0.82 ALDH1A1 (0.42) KDM4EALDH1A1MAPTL3MBTL1ALOX15
SCHEMBL936114 0.82 KDM4E (0.55) KDM4EALDH1A1MAPTL3MBTL1ALOX15
SCHEMBL3538383 0.82 KDM4E (0.41) KDM4EALDH1A1MAPTL3MBTL1ALOX15
Benzene SCHEMBL1202117 0.82 KDM4E (0.55) KDM4EALDH1A1MAPTL3MBTL1ALOX15
SCHEMBL22031727 0.79 KDM4E (0.52) KDM4EALDH1A1MAPTL3MBTL1ALOX15
SCHEMBL7194177 0.78 KDM4E (0.38) KDM4EALDH1A1MAPTL3MBTL1ALOX15
SCHEMBL1202477 0.78 KDM4E (0.50) KDM4EALDH1A1MAPTL3MBTL1ALOX15
SCHEMBL3963715 0.78 P2RX7 (0.48) KDM4EALDH1A1MAPTL3MBTL1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1505966-A4 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2006-08-30 EP disclosed
EP-1505966-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2005-02-16 EP disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed
EP-0329606-A2 Antibiotics from myxocuccos CIBA-GEIGY AG (CH) 1989-08-23 EP disclosed